id	keyword
inlawrev-25507	patent
inlawrev-25507	drug
inlawrev-25507	evergreening
inlawrev-25507	note
inlawrev-25507	supra
inlawrev-25507	act
inlawrev-25507	pharmaceutical
inlawrev-25507	humira
inlawrev-25507	companies
inlawrev-25507	generic
inlawrev-25507	innovation
inlawrev-25507	company
inlawrev-25507	supra note
inlawrev-25507	abbvie
inlawrev-25507	factor
inlawrev-25507	uspto
inlawrev-25507	exclusivity
inlawrev-25507	law
inlawrev-25507	federal
inlawrev-25507	market